Crossmark

Physician requests by patients with malignant pleural mesothelioma in Japan

Crossref DOI link: https://doi.org/10.1186/s12885-019-5591-7

Published Online: 2019-04-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagamatsu, Yasuko

Oze, Isao

Aoe, Keisuke

Hotta, Katsuyuki

Kato, Katsuya

Nakagawa, Junko

Hara, Keiko

Kishimoto, Takumi

Fujimoto, Nobukazu http://orcid.org/0000-0002-4516-0433
Funding

Funding for this research was provided by:

Japan Labour Health and Welfare Organization

Ministry of Health, Labor and Welfare, Japan
License Information

Text and Data Mining valid from 2019-04-25
More Information

Article History

Received: 18 May 2018

Accepted: 9 April 2019

First Online: 25 April 2019

Ethical approval and consent to participate

: This study was approved by the institutional review board of Okayama Rosai Hospital (approval no. 2017–22). This study was also approved by the institutional review board of each hospital or institution that distributed the questionnaire to their patients, according to their policy. The study was conducted based on the ethical principles of avoiding harm, voluntary participation, anonymity, and protection of privacy and personal information. The purpose, procedures, and confidentiality of the study were explained in written format. The participants were informed that nonparticipation would not disadvantage them. Return of the answered questionnaire was considered to constitute the patient’s consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.